S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team (2013/5/15)|
|Achillion Reports First Quarter 2013 Financial Results (2013/5/7)|
|Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV (2013/4/16)|
|Achillion Presents New Data on ACH-3102 to Treat Hepatitis C at the International Liver Congress (2013/4/23)|
|Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients (2013/4/23)|
|Achillion to Present at Two Upcoming Investor Conferences (2013/3/1)|
|Achillion to Present at Three Upcoming Investor Conferences (2013/5/9)|
|Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock (2013/2/21)|
|Achillion Pharmaceuticals Announces Closing of Public Offering (2013/2/27)|
|Achillion Pharmaceuticals Announces Proposed Public Offering of Common Stock (2013/2/20)|
Click above to view more mutual fund data and stats for achn - Achillion Pharmaceuticals, Inc..